Wikidata

(Q45217739)

English

Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trial

scientific article published in January 2004

In more languages

Statements

title
Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
author name string
Ramesh K Ramanathan
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Jimmy J Hwang
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
William C Zamboni
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Frank A Sinicrope
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Howard Safran
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Michael K Wong
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Martin Earle
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Adam Brufsky
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Terry Evans
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Monica Troetschel
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Christine Walko
series ordinal
11
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Roger Day
series ordinal
12
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Helen X Chen
series ordinal
13
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
Sydney Finkelstein
series ordinal
14
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
publication date
1 January 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
page(s)
858-865
1 reference
stated in
Europe PubMed Central
PubMed ID
15641483
retrieved
10 December 2017
cites work

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45217739&oldid=2070398341"